Reproductive and Developmental Medicine
Reproductive and Developmental Medicine is an international peer-reviewed journal that mainly reports the latest research in reproductive medicine and developmental biology. Published on a quarterly basis, the journal is co-sponsored by Chinese Medical Association, Obstetrics and Gynecology Hospital of Fudan University, and Shanghai Institute for Biomedical and Pharmaceutical Technologies. The editor-in-chief is Prof. XU Congjian.
Overview and history
Reproductive and Developmental Medicine is the first international academic journal in the field of reproductive medicine and developmental biology in mainland China. The journal, formerly known as the Journal of Reproduction and Contraception , was established in 1989 against the backdrop of China’s family planning policies. It was edited and published by the editorial office of Reproduction & Contraception .Starting on January 1, 2016, China’s one-child policy came to an end. In April of the same year, the State Administration of Press, Publication, Radio, Film and Television (SAPPRFT) of the People's Republic of China officially approved the renaming of the Journal of Reproduction and Contraception to its current title, Reproductive and Developmental Medicine. At the same time, the journal’s governor was changed from the National Health and Family Planning Commission to the China Association for Science and Technology. Its sponsors were updated from the Shanghai Family Planning Research Institute to the Chinese Medical Association, Obstetrics and Gynecology Hospital of Fudan University, and Shanghai Institute for Biomedical and Pharmaceutical Technologies.
In 2017, Reproductive and Developmental Medicine began publication on the Medknow under Wolters Kluwer. Since 2022, the publisher has transitioned to the Lippincott Williams & Wilkins of Wolters Kluwer. No fees are charged for submissions, with Obstetrics and Gynecology Hospital of Fudan University covering the article processing charges.